TY  - JOUR

T1  - Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - PharmacoEconomics

UR  - http://eprints.whiterose.ac.uk/133239/

PY  - 2019/01/24

AU  - Tappenden P

AU  - Carroll C

AU  - Stevens J

AU  - Simpson E

AU  - Thokala P

AU  - Wong R

AU  - Wright J

AU  - Auer R

ED  - 

DO  - DOI: 10.1007/s40273-018-0680-z

PB  - Springer Science and Business Media LLC

VL  - 37

IS  - 1

SP  - 7

EP  - 18

Y2  - 2024/12/21

ER  -